Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada: a test-negative design study
Hannah Chung, Siyi He, Sharifa Nasreen, Maria E. Sundaram, Sarah A. Buchan, Sarah E. Wilson, Branson Chen, Andrew Calzavara, Deshayne B. Fell, Peter C. Austin, Kumanan Wilson, Kevin L. Schwartz, Kevin A. Brown, Jonathan B. Gubbay, Nicole E. Basta, Salaheddin M. Mahmud, Christiaan H. Righolt, Lawrence W. Svenson, Shannon E. MacDonald, Naveed Z. Janjua, Mina Tadrous, Jeffrey C. Kwong
medRxiv 2021.05.24.21257744; doi: https://doi.org/10.1101/2021.05.24.21257744